Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
STMN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPR55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RAB7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FEZ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOTAIRM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FIGLA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728283 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TXNDC15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAH6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC42SE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTR7P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP2A7P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCNN1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VAMP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARID5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARID4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on